Rescue therapy outcomes with GP IIb/IIIa inhibitors: IA versus IV administration
| Outcome | IA GP IIb/IIIa % (95% CI) | I2 | IV GP IIb/IIIa % (95% CI) | I2 | P Value |
|---|---|---|---|---|---|
| Postoperative clinical stroke | 14.0 (7.0–26.0) | 70 | 14.0 (8.0–26.0) | 0 | .94 |
| Postoperative infarct on imaging | 33.0 (20.0–50.0) | 58 | 23.0 (13.0–36.0) | 28 | .30 |
| Postoperative hemorrhage | 5.0 (3.0–9.0) | 0 | 7.0 (3.0–15.0) | 18 | .66 |
| Perioperative morbidity from stroke/hemorrhage | 10.0 (7.0–15.0) | 0 | 13.0 (6.0–27.0) | 34 | .57 |
| Perioperative mortality from stroke/hemorrhage | 6.0 (4.0–10.0) | 0 | 8.0 (4.0–14.0) | 0 | .53 |
| Long-term good neurologic outcome | 83.0 (76.0–88.0) | 0 | 78.0 (69.0–85.0) | 10 | .37 |
| Long-term morbidity | 14.0 (10.0–21.0) | 0 | 17.0 (11.0–25.0) | 2 | .56 |
| Recanalization rate | 77.0 (66.0–85.0) | 58 | 70.0 (57.0–80.0) | 33 | .36 |